NTA (actually economic NTA) is slightly below my expectation, the the downward revaluation is somehow a surprise. Underlining earning is a little over my expectation, seems the rent contraction in Q1 wasn't that bad.Still happy to hold.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025